Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-13

FDA Approved: ERTAPENEM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for Ertapenem (ERTAPENEM) by Eugia US LLC. The action relates to a modification/expansion of the drug’s regulatory autho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERTAPENEM (ertapenem)

Snippet

SUPPL AP for ERTAPENEM (ERTAPENEM)